Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2020

01-12-2020 | Obesity | Research

The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies

Authors: Fathimah S. Sigit, Dicky L. Tahapary, Stella Trompet, Erliyani Sartono, Ko Willems van Dijk, Frits R. Rosendaal, Renée de Mutsert

Published in: Diabetology & Metabolic Syndrome | Issue 1/2020

Login to get access

Abstract

Background

The prevalence of metabolic syndrome varies among populations with different ethnicities. Asian populations develop metabolic complications at lower amounts of adiposity than western populations. The role of abdominal obesity in the metabolic differences between the two populations is poorly understood.

Objectives

Our objectives were to estimate the prevalence of metabolic syndrome and the relative contribution of its components in the Indonesian and the Dutch population, as well as to examine the associations of overall and abdominal obesity with metabolic syndrome.

Methods

In this cross-sectional study of middle-aged adults in the Netherlands Epidemiology of Obesity Study (n = 6602) and the Indonesian National Health Surveillance (n = 10,575), metabolic syndrome was defined by the unified IDF and AHA/NHLBI criteria. We performed logistic and linear regressions to examine associations of BMI and waist circumference with the metabolic syndrome, mutually adjusted for waist circumference and BMI.

Results

The prevalence of metabolic syndrome was 28% and 46% in Indonesian men and women, and 36% and 24% in Dutch men and women. The most prominent components were hypertension (61%) and hyperglycemia (51%) in the Indonesian, and hypertension (62%) and abdominal obesity (40%) in the Dutch population. Per SD in BMI and waist circumference, odds ratios (ORs, 95% CI) of metabolic syndrome were 1.5 (1.3–1.8) and 2.3 (1.9–2.7) in Indonesian men and 1.7 (1.2–2.5) and 2.9 (2.1–4.1) in Dutch men. The ORs of metabolic syndrome were 1.4 (1.2–1.6) and 2.3 (2.0–2.7) in Indonesian women and 1.0 (0.8–1.3) and 4.2 (3.2–5.4) in Dutch women.

Conclusion

More Indonesian women than men have metabolic syndrome, whereas the opposite is true for the Dutch population. In both the Indonesian and the Dutch populations, hypertension is the primary contributor to the prevalence of metabolic syndrome. In both populations, abdominal adiposity was more strongly associated with metabolic syndrome than overall adiposity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ranasinghe P, et al. Prevalence and trends of metabolic syndrome among adults in the Asia-Pacific region: a systematic review. BMC Public Health. 2017;17:101.CrossRef Ranasinghe P, et al. Prevalence and trends of metabolic syndrome among adults in the Asia-Pacific region: a systematic review. BMC Public Health. 2017;17:101.CrossRef
2.
go back to reference Alberti KGMM, et al. Joint scientific statement, harmonizing the metabolic syndrome, a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world health federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–5.CrossRef Alberti KGMM, et al. Joint scientific statement, harmonizing the metabolic syndrome, a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world health federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–5.CrossRef
4.
go back to reference Grundy SM, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112:2735–52.CrossRef Grundy SM, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112:2735–52.CrossRef
5.
go back to reference Tchernof A, Despres JA. Patophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404.CrossRef Tchernof A, Despres JA. Patophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404.CrossRef
6.
go back to reference Sniderman DA, et al. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol. 2007;36:220–5.CrossRef Sniderman DA, et al. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol. 2007;36:220–5.CrossRef
7.
go back to reference Araneta MRG, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in filipina-American women; a high-risk non-obese population. Diabetes Care. 2002;25(3):494–9.CrossRef Araneta MRG, Wingard DL, Barrett-Connor E. Type 2 diabetes and metabolic syndrome in filipina-American women; a high-risk non-obese population. Diabetes Care. 2002;25(3):494–9.CrossRef
8.
go back to reference Araneta MRG, Barret-Connor E. Subclinical coronary atherosclerosis in asymptomatic filipino and white women. Circulation. 2004;110:2817–23.CrossRef Araneta MRG, Barret-Connor E. Subclinical coronary atherosclerosis in asymptomatic filipino and white women. Circulation. 2004;110:2817–23.CrossRef
9.
go back to reference Wang D, et al. Ethnic differences in body composition and obesity related risk factors: study in chinese and white males living in China. PLoS ONE. 2011;6(5):e19835.CrossRef Wang D, et al. Ethnic differences in body composition and obesity related risk factors: study in chinese and white males living in China. PLoS ONE. 2011;6(5):e19835.CrossRef
10.
go back to reference Eastwood SV, et al. Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: the SABRE study. Obesity. 2015;23:699–706.CrossRef Eastwood SV, et al. Ethnic differences in associations between fat deposition and incident diabetes and underlying mechanisms: the SABRE study. Obesity. 2015;23:699–706.CrossRef
11.
go back to reference Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.CrossRef Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–7.CrossRef
12.
go back to reference Despres JP, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–49.CrossRef Despres JP, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28:1039–49.CrossRef
13.
go back to reference Neeland IJ, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity. 2013;21:E439–47.PubMed Neeland IJ, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity. 2013;21:E439–47.PubMed
14.
go back to reference Kaess BM, et al. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardio-metabolic risk. Diabetologia. 2012;55:2622–30.CrossRef Kaess BM, et al. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardio-metabolic risk. Diabetologia. 2012;55:2622–30.CrossRef
15.
go back to reference Kwon H, Kim D, Kim JS. Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study. Sci Rep. 2017;7(1):10955.CrossRef Kwon H, Kim D, Kim JS. Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study. Sci Rep. 2017;7(1):10955.CrossRef
16.
go back to reference Goh VHH, Hart WG. Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women. Maturitas. 2018;107:33–8.CrossRef Goh VHH, Hart WG. Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women. Maturitas. 2018;107:33–8.CrossRef
17.
go back to reference Jelavic MM, Babic Z, Pintaric H. The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction. Arch Med Sci. 2017;13(4):795–806.CrossRef Jelavic MM, Babic Z, Pintaric H. The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction. Arch Med Sci. 2017;13(4):795–806.CrossRef
18.
go back to reference Ladeiras-Lopes R, Sampaio F, Bettencourt N, Fontes-Carvalho R, Ferreira N, Leite-Moreira A, Gama V. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol (Engl Ed). 2017;70(5):331–7.CrossRef Ladeiras-Lopes R, Sampaio F, Bettencourt N, Fontes-Carvalho R, Ferreira N, Leite-Moreira A, Gama V. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol (Engl Ed). 2017;70(5):331–7.CrossRef
19.
go back to reference Park J, et al. A comparison of the prevalence of the metabolic syndrome in the United States (US) and Korea in young adults aged 20 to 39 years. Asia Pac J Clin Nutr. 2008;17(3):471–82.PubMed Park J, et al. A comparison of the prevalence of the metabolic syndrome in the United States (US) and Korea in young adults aged 20 to 39 years. Asia Pac J Clin Nutr. 2008;17(3):471–82.PubMed
20.
go back to reference Agyemang C, et al. Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations. Diabet Med. 2012;29:1159–64.CrossRef Agyemang C, et al. Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations. Diabet Med. 2012;29:1159–64.CrossRef
21.
go back to reference Agyemang C, et al. Educational inequalities in metabolic syndrome vary by ethnic group: evidence from the SUNSET study. Int J Cardiol. 2010;141:266–74.CrossRef Agyemang C, et al. Educational inequalities in metabolic syndrome vary by ethnic group: evidence from the SUNSET study. Int J Cardiol. 2010;141:266–74.CrossRef
22.
go back to reference de Mutsert R, et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol. 2013;28(6):513–23.CrossRef de Mutsert R, et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol. 2013;28(6):513–23.CrossRef
25.
go back to reference World Health Organization, Western Pacific Region. The asia-pacific perspective: redefining obesity and its treatment. Health Communications Australia: February 2000. World Health Organization, Western Pacific Region. The asia-pacific perspective: redefining obesity and its treatment. Health Communications Australia: February 2000.
26.
go back to reference Kamso S. Body mass index, total cholesterol, and ratio total to HDL cholesterol were determinants of metabolic syndrome in the Indonesian elderly. Med J Indones. 2007;16:195–200.CrossRef Kamso S. Body mass index, total cholesterol, and ratio total to HDL cholesterol were determinants of metabolic syndrome in the Indonesian elderly. Med J Indones. 2007;16:195–200.CrossRef
27.
go back to reference Soewondo P, et al. Prevalence of metabolic syndrome using NCEP/ATP III criteria in Jakarta, Indonesia: the Jakarta primary non-communicable disease risk factors surveillance 2006. Acta Med Indones. 2010;42(4):199–203.PubMed Soewondo P, et al. Prevalence of metabolic syndrome using NCEP/ATP III criteria in Jakarta, Indonesia: the Jakarta primary non-communicable disease risk factors surveillance 2006. Acta Med Indones. 2010;42(4):199–203.PubMed
28.
go back to reference Mboi N, et al. On the road to universal health care in Indonesia, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:581–91.CrossRef Mboi N, et al. On the road to universal health care in Indonesia, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:581–91.CrossRef
29.
go back to reference Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013;9:63.CrossRef Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013;9:63.CrossRef
30.
go back to reference Rachmi CN, Li M, Baur LA. Overweight and obesity in Indonesia: prevalence and risk factors—a literature review. Public Health. 2017;147:20–9.CrossRef Rachmi CN, Li M, Baur LA. Overweight and obesity in Indonesia: prevalence and risk factors—a literature review. Public Health. 2017;147:20–9.CrossRef
31.
go back to reference Slagter SN, et al. Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study. Endocr Connect. 2016;6:278–88.CrossRef Slagter SN, et al. Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study. Endocr Connect. 2016;6:278–88.CrossRef
32.
go back to reference Bos MB, et al. The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60. Ned Tijdschr Geneeskd. 2007;151(43):2382–8.PubMed Bos MB, et al. The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60. Ned Tijdschr Geneeskd. 2007;151(43):2382–8.PubMed
33.
go back to reference Lesser IA, Gasevic D, Lear SA. The effect of body fat distribution on ethnic differences in cardiometabolic risk factors of Chinese and Europeans. Appl Physiol Nutr Metab. 2013;38:701–6.CrossRef Lesser IA, Gasevic D, Lear SA. The effect of body fat distribution on ethnic differences in cardiometabolic risk factors of Chinese and Europeans. Appl Physiol Nutr Metab. 2013;38:701–6.CrossRef
34.
go back to reference Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet. 1982;1(8282):1165–8.CrossRef Messerli FH. Cardiovascular effects of obesity and hypertension. Lancet. 1982;1(8282):1165–8.CrossRef
35.
go back to reference Ferrannini E. The haemodynamics of obesity: a theoretical analysis. J Hypertens. 1992;10(11):1417–23.CrossRef Ferrannini E. The haemodynamics of obesity: a theoretical analysis. J Hypertens. 1992;10(11):1417–23.CrossRef
36.
go back to reference Zhang R, Reisin E. Obesity-hypertension: the effects on cardiovascular and renal systems. Am J Hypertens. 2000;13:1308–14.CrossRef Zhang R, Reisin E. Obesity-hypertension: the effects on cardiovascular and renal systems. Am J Hypertens. 2000;13:1308–14.CrossRef
37.
go back to reference Frohlich ED. Obesity and hypertension hemodynamic aspects. Ann Epidemiol. 1991;1:287–93.CrossRef Frohlich ED. Obesity and hypertension hemodynamic aspects. Ann Epidemiol. 1991;1:287–93.CrossRef
38.
go back to reference Messerli FH, et al. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med. 1983;74(5):808–12.CrossRef Messerli FH, et al. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med. 1983;74(5):808–12.CrossRef
39.
go back to reference Pramono LA, Harbuwono DS. Managing hypertriglyceridemia in daily practice. Acta Med Indones-Indones J Intern Med. 2015;47:3. Pramono LA, Harbuwono DS. Managing hypertriglyceridemia in daily practice. Acta Med Indones-Indones J Intern Med. 2015;47:3.
40.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2011;34(Supplement 1):S11–61.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2011;34(Supplement 1):S11–61.CrossRef
41.
go back to reference Immanuel J, Simmons D. A perspective on the accuracy of blood glucose meters during pregnancy. Diabetes Care. 2018;41(10):2053–8.CrossRef Immanuel J, Simmons D. A perspective on the accuracy of blood glucose meters during pregnancy. Diabetes Care. 2018;41(10):2053–8.CrossRef
42.
go back to reference Dunne N, et al. Accuracy evaluation of contour ®plus compared with four blood glucose monitoring systems. Diabetes Ther. 2015;6(3):377–88.CrossRef Dunne N, et al. Accuracy evaluation of contour ®plus compared with four blood glucose monitoring systems. Diabetes Ther. 2015;6(3):377–88.CrossRef
43.
go back to reference Parwaiz M, et al. Assessment of glucose meter performance at the antenatal diabetes clinic: exploration of patient-related and pre-analytical factors. Ann Clin Biochem. 2014;51(1):47–53.CrossRef Parwaiz M, et al. Assessment of glucose meter performance at the antenatal diabetes clinic: exploration of patient-related and pre-analytical factors. Ann Clin Biochem. 2014;51(1):47–53.CrossRef
44.
go back to reference Nathan DM, et al. Impaired fasting glucose and impaired glucose tolerance, implications for care. Diabetes Care. 2007;30(3):753–9.CrossRef Nathan DM, et al. Impaired fasting glucose and impaired glucose tolerance, implications for care. Diabetes Care. 2007;30(3):753–9.CrossRef
Metadata
Title
The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies
Authors
Fathimah S. Sigit
Dicky L. Tahapary
Stella Trompet
Erliyani Sartono
Ko Willems van Dijk
Frits R. Rosendaal
Renée de Mutsert
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2020
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-019-0503-1

Other articles of this Issue 1/2020

Diabetology & Metabolic Syndrome 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.